India Pharma Logistics Ka Big Overhaul! Costs Ghatayengi, Global Market Mein India Banega Champion!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorIshaan Verma|Published at:
India Pharma Logistics Ka Big Overhaul! Costs Ghatayengi, Global Market Mein India Banega Champion!
Overview

Bhai log, suno! India ki Department of Pharmaceuticals (DoP) ne ek dum mast initiative shuru kiya hai. Apne pharma aur medical device sector ke liye logistics ko ekdum next level pe le jaane ki planning chal rahi hai. Reality yeh hai ki apna domestic logistics cost global average se lagbhag **15%** zyada hai, aur delivery mein bhi time lagta hai. Is baar target hai cost cutting aur supply chain ko itna strong banana ki India global market mein rock kare!

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Yeh sirf emergency mein freight charges badhne ka reaction nahi hai, balki 98 din ke average inventory holding period ko 64 din jaisa global benchmark lane ka bada plan hai. Isse pharma aur medical device sector ko global level par aur zyada competitive banane mein madad milegi.

Abhi Red Sea waali dikkaton ne toh kamaal kar diya, freight 200-300% tak badh gaya aur transit time double ho gaya. Isse exports pe bahut impact hua, companies ko apna stock zyada rakhna pada, jisse crores ka nuksan ho sakta hai. Isliye DoP ko laga ki ab sirf emergency measures nahi, balki poore system ko hi sudharna hoga.

Ek consultancy aa rahi hai jo poora supply chain, raw material se leke final delivery tak, sabko scan karegi. Kahan traffic jam hai (bottlenecks), kahan storage mein dikkat hai, customs mein kya problem hai, cold chain mein gadbad hai ya nahi, sab pata lagaya jayega.

Government ki National Logistics Policy (NLP) ka bhi yahi goal hai ki total logistics costs ko GDP ke 5% se kam laya jaye. Aur yeh ekdum zaroori hai kyunki India generics aur vaccines mein toh king hai, par logistics ki wajah se export growth ruk jaata hai.

Cold chain toh jaise ek nightmare hai, khaas kar gaon mein. Lagbhag 25% vaccines kharab ho jaati hain. MedTech sector bhi imports pe bahut depend karta hai, jisse trade deficit badhta hai.

Asli masle infrastructure ki kami aur alag-alag system hain. Iske liye policy mein bade badlav aur ports, hubs, digital systems mein heavy investment ki zaroorat hai. Global regulations bhi ek challenge hain jinko manage karna hoga.

Umeed hai ki isse pharma aur medical products abroad aur zyada competitive honge, aur India ki global healthcare market mein position aur mazboot hogi.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.